Literature DB >> 9605946

Effects of germinated barley foodstuff on dextran sulfate sodium-induced colitis in rats.

O Kanauchi1, T Nakamura, K Agata, K Mitsuyama, T Iwanaga.   

Abstract

Germinated barley foodstuff (GBF), derived from the aleurone and scutellum fractions of germinated barley, is rich in glutamine and low-lignified hemicellulose, and increases mucosal protein, RNA, and DNA content in the intestine when fed to normal rats. The aim of this study was to evaluate the effects of feeding GBF or germinated gramineous seeds on experimental ulcerative colitis. Sprague-Dawley rats that received 3% dextran sulfate sodium in their diets were used as an experimental colitis model. The effects of sulfasalazine, a drug used to treat inflammatory bowel disease, were compared with those of GBF. After rats had consumed diets containing GBF or various aleurone and scutellum fractions, mucosal damage; the content of mucosal protein, RNA, and DNA in the colo-rectum; and serum interleukin-8 and alpha1-acid glycoprotein levels were assessed. GBF and germinated seeds more effectively prevented bloody diarrhea and mucosal damage in colitis compared with controls and rats receiving sulfasalazine, but non-germinated samples did not have a protective effect. GBF increased mucosal protein and RNA content in the colitis model. The consumption of GBF appears to prevent inflammation in a colitis model, and its effect seems to be related to the germination process. GBF and germinated seeds have the potential to serve as nutritional therapy for ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605946     DOI: 10.1007/s005350050067

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  14 in total

1.  Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats.

Authors:  Y Araki; A Andoh; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

Review 3.  Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Authors:  Dimitrios Damaskos; George Kolios
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

4.  Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats.

Authors:  Ping Zheng; Feng-Li Niu; Wen-Zhong Liu; Yao Shi; Lun-Gen Lu
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 5.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

6.  Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis.

Authors:  Takashi Nishimura; Akira Andoh; Takayoshi Hashimoto; Ayako Kobori; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Clin Biochem Nutr       Date:  2010-02-24       Impact factor: 3.114

7.  Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity.

Authors:  Yu You; Jian-Jiang Fu; Jun Meng; Guo-Dong Huang; Yu-Hui Liu
Journal:  Dig Dis Sci       Date:  2008-11-26       Impact factor: 3.199

8.  Optimization of technology for dietary fiber extraction from Maixiansan by response surface methodology.

Authors:  Hui-Qing Lv; Changfeng Hu; Hai-Ping Zhong; Hong-Bin Zheng; Chengping Wen
Journal:  Chin Med       Date:  2012-12-29       Impact factor: 5.455

9.  Malt in combination with Lactobacillus rhamnosus increases concentrations of butyric acid in the distal colon and serum in rats compared with other barley products but decreases viable counts of cecal bifidobacteria.

Authors:  Camilla E Bränning; Margareta E Nyman
Journal:  J Nutr       Date:  2010-11-24       Impact factor: 4.798

10.  CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.

Authors:  A Suzuki; T Hanada; K Mitsuyama; T Yoshida; S Kamizono; T Hoshino; M Kubo; A Yamashita; M Okabe; K Takeda; S Akira; S Matsumoto; A Toyonaga; M Sata; A Yoshimura
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.